TGTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
TG THERAPEUTICS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$53.30−0.67 (-1.24%)
Close on Oct 19, 2026
- Market cap
- $8.38B
- P/E (TTM)
- 19.5
- Dividend yield
- –
SEC filings
40 of Tg Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 3, 2026 | Aug 3, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2026 | Jun 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 3, 2026 | Jun 3, 2026 | SEC EDGAR |
| Current report | 8-K | May 27, 2026 | May 27, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 6, 2026 | SEC EDGAR |
| Current report | 8-K | May 6, 2026 | May 6, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 11, 2026 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 18, 2026 | Mar 20, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 27, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2026 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2026 | Jan 13, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 3, 2025 | Nov 3, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 8, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 4, 2025 | Aug 4, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2025 | Jun 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 9, 2025 | SEC EDGAR |
| Current report | 8-K | May 5, 2025 | May 5, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 12, 2025 | Apr 30, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 3, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 3, 2025 | Mar 3, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 14, 2025 | Jan 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 4, 2024 | Nov 4, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 9, 2024 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2023 | Aug 9, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 2, 2024 | Aug 6, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 14, 2024 | Jun 17, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 6, 2024 | SEC EDGAR |
| Current report | 8-K | May 1, 2024 | May 1, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 14, 2024 | Apr 29, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Feb 29, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 28, 2024 | Feb 28, 2024 | SEC EDGAR |
| Current report | 8-K | Jan 7, 2024 | Jan 10, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2023 | Nov 6, 2023 | SEC EDGAR |
| Current report | 8-K | Nov 1, 2023 | Nov 1, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2023 | Aug 4, 2023 | SEC EDGAR |
| Current report | 8-K | Jul 28, 2023 | Aug 1, 2023 | SEC EDGAR |
| Current report | 8-K | Jun 14, 2023 | Jun 15, 2023 | SEC EDGAR |